Proton FLASH radiation therapy
- Energy
- Protons at ultra-high dose rate
- Delivery
- Under one second
- Stage
- Early clinical research
FLASH delivers radiation hundreds of times faster than conventional machines. In animal studies, healthy tissue tolerated the same dose far better, while tumors were controlled just as well.
For a nasal tumor, the organs at risk are the eyes, skin and brain, all millimeters away. A treatment that spares them could allow higher, more effective doses with fewer side effects. The University of Pennsylvania built one of the first proton FLASH systems, and this research is a central focus of the fund.
Trials
Penn Vet's study of FLASH proton radiation in pet dogs with naturally occurring head and neck tumors, the work the fund supports.1
In 2026, Penn opened the first U.S. human trial of conformal FLASH proton therapy, building directly on the canine trial.1
Radiation is the current standard of care. FLASH aims to make it safer and stronger at the same time.